Status:
COMPLETED
The Effect of Transcutaneous Vagus Nerve Stimulation on Cognitive Function
Lead Sponsor:
University of Ostrava
Conditions:
Cognitive Function
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Cognitive health is generally considered a key component of quality of life. Current evidence indicates that a large number of individuals are at a high risk for cognitive impairment from many causes ...
Detailed Description
Cognitive health is generally considered a key component of quality of life. Current evidence indicates that a large number of individuals are at high risk for cognitive impairment from many causes as...
Eligibility Criteria
Inclusion
- relatively healthy adults
Exclusion
- cardiovascular disease (e.g. arythmia, history of coronary heart disease, history of stroke),
- severe mental condition (e.g. significant depression, schizophrenia, autism, significant anxiety disorder)
- severe neurological condition (e.g. epilepsy, brain tumors, significant migraine, traumatic brain injury)
- brain surgery
- pregnancy
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04070547
Start Date
January 1 2019
End Date
June 30 2020
Last Update
May 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ostrava, Faculty of Medicine
Ostrava, Czechia